Year: 2024
Type: article
Abstract: Background: Psychedelic-assisted therapy (PAT) is experiencing a resurgence, with expanding evidence proving its efficacy for treatment-resistant psychiatric-mental health conditions. Psychiatric-mental health nurses (PMHNs) are uniquely positioned to provide PAT due to their integrated care capabilities, yet their roles are poorly defined. Aim: This review synthesizes PAT's clinical applications, mechanisms, and issues, focusing on PMHNs' preparation, dosing, and integration roles, while proposing training and policy guidelines to enhance their involvement. Methods: A systematic search of peer-reviewed literature, clinical trials, meta-analyses, and nursing scholarship was conducted. The databases of PubMed, PsycINFO, and CINAHL were used to conduct searches for 2000-2025 studies related to the use of psilocybin, MDMA, and LSD. Results: PAT has robust effectiveness for depression, PTSD, substance use disorders, and end-of-life distress with effect sizes of 0.7-1.2. PMHNs enter safety and outcomes through trust building, monitoring, and integration, but only lead 5% of trials. Legal barriers, lack of funding, and inequities persist. Conclusion: PMHNs are the key to equitable adoption of PAT, requiring greater training, research leadership, and policy leverage to achieve maximum benefit.
DOI: 10.64483/20251153
Authors: Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly
Institutions: Qatif Central Hospital, Ministry of Health
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: hybrid
OpenAlex ID: W7089358245
FWCI:
Cites:
Cited by:
Related to: